|
UNITED STATES |
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
For the month of February 2022
Commission File Number 001-37626
Mesoblast Limited
(Exact name of Registrant as specified in its charter)
Not Applicable
(Translation of Registrant’s name into English)
Australia
(Jurisdiction of incorporation or organization)
Silviu Itescu
Chief Executive Officer and Executive Director
Level 38
55 Collins Street
Melbourne 3000
Australia
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F ☑ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ☐ No ☑
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ☐ No ☑
INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K
On February 25, 2022, Mesoblast Limited submitted a Final Director’s Interest Notice to the Australian Securities Exchange, a copy of which is attached to this report as Exhibit 99.1, and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.
|
|
|
|
|
|
|
|
|
Mesoblast Limited |
|
|
|
|
|
/s/ Niva Sivakumar |
|
|
|
|
|
|
|
|
|
|
|
Niva Sivakumar |
|
|
|
|
|
Company Secretary
|
|
|
Dated: February 28, 2022
INDEX TO EXHIBITS
|
|
|
|
|
Item |
|
|
|
|
|
|
|
99.1 |
|
Final Director’s Interest Notice, Donal O’Dwyer, dated February 25, 2022. |
|
|
|
|
|
|
|
|
Exhibit 99.1
Appendix 3Z
Final Director’s Interest Notice
Rule 3.19A.3
Appendix 3Z
Final Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
|
|
Name of entity |
Mesoblast Limited |
|
|
ABN |
68 109 431 870 |
We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.
|
Name of director |
Donal O’Dwyer |
|
Date of last notice |
20 March 2020 |
|
Date that director ceased to be director |
25 February 2022 |
Part 1 – Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
|
Number & class of securities 100,000 options
|
+ See chapter 19 for defined terms.
|
11/3/2002 |
Appendix 3Z Page 1 |
Appendix 3Z
Final Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
|
Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest
|
Number & class of securities |
|
Dundrum Investments Pty Ltd, trustee for the director’s family trust |
1,234,392 ordinary shares |
Part 3 – Director’s interests in contracts
|
Detail of contract |
N/A |
|
Nature of interest
|
N/A |
|
Name of registered holder (if issued securities)
|
N/A |
|
No. and class of securities to which interest relates
|
N/A |
+ See chapter 19 for defined terms.
|
Appendix 3Z Page 2 |
11/3/2002 |